Explore Melanotan-I (afamelanotide) dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Melanotan-I (afamelanotide) is a potent, MC1-selective alpha-MSH analog approved in implant form as SCENESSE for the prevention of phototoxicity in adults with erythropoietic protoporphyria (EPP). It shares a research origin with Melanotan II at the University of Arizona but followed a fundamentally different commercial path. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when working with Melanotan-I.
40 Melanotan-I reconstitution calculations have been logged by the WPA community. The most common dose entered is 0.25mg (8 calculations). The median dose across all sessions is 250mcg. The most common bacteriostatic water volume is 2mL. The most popular vial size is 10mg (32 sessions).
World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community.